Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Rezek, D."" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-3 z 3
    Tytuł:
    Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: results of the prospective observational EvAluate-TM study.
    Autorzy:
    Wallwiener M; Department of Gynecology, University of Tübingen, Tübingen, Germany.; Department of Gynecology, University Hospital Heidelberg, Heidelberg, Germany.
    Nabieva N; Department of Gynecology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Universitätsstrasse 21-23, 91054, Erlangen, Germany.
    Feisst M; Institute of Medical Biometry and Informatics, University of Heidelberg, Heidelberg, Germany.
    Fehm T; Department of Gynecology, Heinrich Heine University of Dusseldorf, Dusseldorf, Germany.
    de Waal J; Department of Gynecology, Dachau Clinic, Dachau, Germany.
    Rezai M; Luisen-Hospital Dusseldorf, Dusseldorf, Germany.
    Baier B; Department of Gynecology, Dachau Clinic, Dachau, Germany.
    Baake G; Oncological Medical Practice Pinneberg, Pinneberg, Germany.
    Kolberg HC; Marien-Hospital Bottrop, Bottrop, Germany.
    Guggenberger M; Tuttlingen Clinic, Tuttlingen, Germany.
    Warm M; Breast center, Department of Gynecology, University Hospital Cologne, Cologne, Germany.; Breast Center, Clinics of Cologne gGmbH Holweide, Cologne, Germany.
    Harbeck N; Breast center, Department of Gynecology, University Hospital Cologne, Cologne, Germany.; Department of Gynecology and Obstetrics, Breast Center and CCC Munich, University Hospital Munich, Munich, Germany.
    Wuerstlein R; Breast center, Department of Gynecology, University Hospital Cologne, Cologne, Germany.; Department of Gynecology and Obstetrics, Breast Center and CCC Munich, University Hospital Munich, Munich, Germany.
    Deuker JU; Vinzenz-Hospital Hanover GmbH, Hanover, Germany.
    Dall P; Department of Gynecology, Lüneburg Clinic, Lüneburg, Germany.
    Richter B; Elbland Clinics, Meissen-Radebeul, Germany.
    Wachsmann G; County hospital Böblingen, Böblingen, Germany.
    Brucker C; Department of Gynecology and Obstetrics, Paracelsus Medical University, Nuremberg, Germany.
    Siebers JW; Department of Gynecology of the St. Josef's Clinic Offenburg, Offenburg, Germany.
    Popovic M; Department of Gynecology, Bayreuth clinic GmbH, CCC ER-EMN, Bayreuth, Germany.
    Kuhn T; Brustzentrum am Diakonie Klinikum Stuttgart, Stuttgart, Germany.
    Wolf C; Medical Center ULM, Ulm, Germany.
    Vollert HW; Medical Campus Bodensee, Klinikum Friedrichshafen, Friedrichshafen, Germany.
    Breitbach GP; Department of Gynecology, Neunkirchen Clinic, Neunkirchen, Germany.
    Janni W; Department of Gynecology, University Hospital Ulm, Ulm, Germany.
    Landthaler R; Gynecological Medical Practice of the County Hospital Krumbach, Krumbach, Germany.
    Kohls A; Evangelic County Hospital Ludwigsfelde-Teltow, Ludwigsfelde-Teltow, Germany.
    Rezek D; Marien-Hospital Wesel, Wesel, Germany.
    Noesselt T; Department of Gynecology of the Sana hospital Hameln, Hameln, Germany.
    Fischer G; Mittweida Hospital gGmbH, Mittweida, Germany.
    Henschen S; Johanniter Hospital Genthin Stendal gGmbH, Hansestadt Stendal, Germany.
    Praetz T; Caritas-Hospital Bad Mergentheim, Bad Mergentheim, Germany.
    Heyl V; Asklepios Paulinen Clinic Wiesbaden, Wiesbaden, Germany.
    Kühn T; Department of Gynecology, Esslingen Clinics a.N, Esslingen, Germany.
    Krauss T; Department of Gynecology Passau, Passau, Germany.
    Thomssen C; Department of Gynecology, Martin-Luther-University Halle-Wittenberg, Halle-Wittenberg, Germany.
    Hohn A; Städtisches Krankenhaus Kiel GmbH, Kiel, Germany.
    Tesch H; Oncology Bethanien Frankfurt, Frankfurt, Germany.
    Mundhenke C; Department of Gynecology, University Hospital Schleswig-Holstein Campus Kiel, Kiel, Germany.
    Hein A; Department of Gynecology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Universitätsstrasse 21-23, 91054, Erlangen, Germany.
    Rauh C; Department of Gynecology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Universitätsstrasse 21-23, 91054, Erlangen, Germany.
    Bayer CM; Department of Gynecology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Universitätsstrasse 21-23, 91054, Erlangen, Germany.
    Schmidt K; Novartis Pharma GmbH Nuremberg, Nuremberg, Germany.
    Belleville E; Clin-Sol GmbH Würzburg, Würzburg, Germany.
    Brucker SY; Department of Gynecology, University of Tübingen, Tübingen, Germany.
    Hadji P; Department of Gynecology, Nordwest Hospital, Frankfurt, Germany.
    Beckmann MW; Department of Gynecology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Universitätsstrasse 21-23, 91054, Erlangen, Germany.
    Wallwiener D; Department of Gynecology, University of Tübingen, Tübingen, Germany.
    Kümmel S; Breast center, Essen Mitte Clinics, Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany.
    Hartkopf A; Department of Gynecology, University of Tübingen, Tübingen, Germany.
    Fasching PA; Department of Gynecology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Universitätsstrasse 21-23, 91054, Erlangen, Germany. .
    Pokaż więcej
    Źródło:
    BMC cancer [BMC Cancer] 2019 Jun 21; Vol. 19 (1), pp. 611. Date of Electronic Publication: 2019 Jun 21.
    Typ publikacji:
    Journal Article; Multicenter Study; Observational Study
    MeSH Terms:
    Patient Compliance*
    Postmenopause*
    Aromatase Inhibitors/*therapeutic use
    Breast Neoplasms/*drug therapy
    Letrozole/*therapeutic use
    Aged ; Female ; Follow-Up Studies ; Humans ; Kaplan-Meier Estimate ; Middle Aged ; Patient Dropouts ; Prospective Studies ; Treatment Outcome ; Treatment Refusal
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Benchmarking of a checklist for the identification of familial risk for breast and ovarian cancers in a prospective cohort.
    Autorzy:
    Rhiem K; Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Cologne, Germany.
    Bücker-Nott HJ; Medical Association Westphalia Lippe, Hagen, Germany.
    Hellmich M; Institute of Medical Statistics and Computational Biology (IMSB), Köln, Germany.
    Fischer H; Klinik für Senologie Evangelische Kliniken Gelsenkirchen, Gelsenkirchen, Germany.
    Ataseven B; Department of Obstetrics and Gynecology, Kliniken Essen-Mitte, Gynäkologie, University Hospital, LMU Munich, Munich, Germany.
    Dittmer-Grabowski C; Kliniken Essen-Mitte, Senologie, Essen, Germany.
    Latos K; Klinik für Gynäkologie und Geburtshilfe, Katharinen-Hospital Unna, Unna, Germany.
    Pelzer V; Brustzentrum GFO Kliniken Bonn-Betriebstätte St. Marien, Bonn, Germany.
    Seifert M; Abteilung für Senologie, Städtisches Klinikum Solingen, Solingen, Germany.
    Schmidt A; Brustzentrum Mühlheim-Oberhausen, Oberhausen, Germany.
    Rezek D; Kooperatives Brustzentrum am Marien-Hospital Wesel, Wesel, Germany.
    Groh U; Brustzentrum Bad Nauheim, Bad Nauheim, Germany.
    Meinerz W; Brustzentrum Paderborn, Paderborn, Germany.
    Crommelinck D; Brustzentrum Luisenkrankenhaus Aachen, Aachen, Germany.
    Hahnen E; Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Cologne, Germany.
    Wesselmann S; German Cancer Society, Berlin, Germany.
    Schmutzler RK; Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Cologne, Germany.
    Pokaż więcej
    Źródło:
    The breast journal [Breast J] 2019 May; Vol. 25 (3), pp. 455-460. Date of Electronic Publication: 2019 Apr 05.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Medical History Taking*
    Breast Neoplasms/*genetics
    Ovarian Neoplasms/*genetics
    BRCA1 Protein/genetics ; BRCA2 Protein/genetics ; Benchmarking ; Breast Neoplasms/epidemiology ; Checklist ; Female ; Genetic Predisposition to Disease ; Germany ; Humans ; Incidence ; Male ; Middle Aged ; Mutation ; Ovarian Neoplasms/epidemiology
    SCR Disease Name:
    Breast Cancer, Familial
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Trastuzumab without chemotherapy in the adjuvant treatment of breast cancer: subgroup results from a large observational study.
    Autorzy:
    Dall P; Department of Obstetrics and Gynaecology and Breast Cancer Center, Städtisches Klinikum Lüneburg, Bögelstraße 1, D-21339, Lüneburg, Germany. .
    Koch T; Breast Center, Klinikum Nürnberg Nord, Prof.-Ernst-Nathan-Str. 1, D-90419, Nürnberg, Germany.
    Göhler T; Onkozentrum Dresden/Freiberg, Leipziger Str. 118, D-01127, Dresden, Germany.
    Selbach J; Oncology Practice, Altmarkt 20 - 24, D-47166, Duisburg, Germany.
    Ammon A; Oncology Practice, Nikolausberger Weg 36, D-37073, Göttingen, Germany.
    Eggert J; Oncology Practice, Xantener Str. 40, D-47441, Moers, Germany.
    Gazawi N; Gyneco-Oncology Practice, Lampestr. 1, D-04107, Leipzig, Germany.
    Rezek D; Gynecology Department, Marien-Hospital, Pastor-Janßen-Str. 8-38, D-46483, Wesel, Germany.
    Wischnik A; Department of Gynecology, Klinikum Augsburg, Stenglinstr. 2, D-86156, Augsburg, Germany.
    Hielscher C; Gyneco-Oncology Practice, Große Parower Str. 47 - 53, D-18435, Stralsund, Germany.
    Schleif N; Roche Pharma AG, Emil-Barell-Str. 1, D-79639, Grenzach-Wyhlen, Germany.
    Cirrincione U; WiSP Research Institute, Karl-Benz-Str. 1, D-40764, Langenfeld, Germany.
    Hinke A; WiSP Research Institute, Karl-Benz-Str. 1, D-40764, Langenfeld, Germany.
    Feisel-Schwickardi G; Department of Obstetrics and Gynecology and Breast Cancer Center, Klinikum Kassel, Mönchebergstr. 41 - 43, D-34125, Kassel, Germany.
    Pokaż więcej
    Źródło:
    BMC cancer [BMC Cancer] 2018 Jan 08; Vol. 18 (1), pp. 51. Date of Electronic Publication: 2018 Jan 08.
    Typ publikacji:
    Journal Article; Observational Study; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Breast Neoplasms/*drug therapy
    Breast Neoplasms/*epidemiology
    Trastuzumab/*administration & dosage
    Adult ; Aged ; Aged, 80 and over ; Breast Neoplasms/genetics ; Breast Neoplasms/pathology ; Disease-Free Survival ; Female ; Humans ; Middle Aged ; Neoplasm Staging ; Receptor, ErbB-2/genetics
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
      Wyświetlanie 1-3 z 3

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies